Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
NCT05056246
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
AMG 133
Sponsor
Amgen